InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: None

Thursday, 12/20/2012 7:57:01 AM

Thursday, December 20, 2012 7:57:01 AM

Post# of 130517
Is the President of the AMA really on the company's advisory board?

From the company's website:

Dr. Owen Garrick

Advisor to the Board of Directors

Dr. Garrick joins Amarantus with over 20 years of pharmaceutical and biotechnology experience. He currently serves as the Chief Operating Officer at Bridge Clinical Research and is President of the American Medical Association Foundation. Prior to that, he was Director of Corporate Strategy and Business Development at McKesson Corporation. Dr. Garrick was Executive Director and Co-Head of Mergers & Acquisitions at Novartis Pharmaceuticals where he oversaw company acquisitions, hybrid equity/license rights deals, mature product divestments and venture investments in biotechnology companies. Prior to Novartis, Dr. Garrick was an associate at Goldman Sachs in New York. Dr. Garrick received his MD from Yale School of Medicine and earned his MBA from Wharton School of Business. He holds an AB from Princeton University, where he has served on the national fund raising board.


Can anyone find any reference to him being the President of the American Medical Association Foundation?

The following link suggest someone else is and was the president of the AMA:

http://www.ama-assn.org/ama/pub/news/news/2012-10-12-wilson-named-wma-president.page

Possibly I didn't spend enough time searching for an answer.

Must be an oversight of mine or the Amarantus Bioscience's vetting process.